Balance Sheet
Cash Flow Statement
Cash from Financing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashChange in TaxesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Mangoceuticals (MGRX) Free Cash Flow (2023 - 2025)

Mangoceuticals' Free Cash Flow history spans 3 years, with the latest figure at -$1.2 million for Q3 2025.

  • For Q3 2025, Free Cash Flow fell 6.47% year-over-year to -$1.2 million; the TTM value through Sep 2025 reached -$5.9 million, down 8.65%, while the annual FY2024 figure was -$4.9 million, 30.53% up from the prior year.
  • Free Cash Flow for Q3 2025 was -$1.2 million at Mangoceuticals, up from -$1.3 million in the prior quarter.
  • Across five years, Free Cash Flow topped out at -$991131.0 in Q1 2024 and bottomed at -$2.3 million in Q1 2025.
  • The 3-year median for Free Cash Flow is -$1.6 million (2024), against an average of -$1.5 million.
  • The largest annual shift saw Free Cash Flow soared 45.3% in 2024 before it tumbled 129.51% in 2025.
  • A 3-year view of Free Cash Flow shows it stood at -$1.7 million in 2023, then soared by 33.47% to -$1.1 million in 2024, then dropped by 9.89% to -$1.2 million in 2025.
  • Per Business Quant, the three most recent readings for MGRX's Free Cash Flow are -$1.2 million (Q3 2025), -$1.3 million (Q2 2025), and -$2.3 million (Q1 2025).